Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl 3-Methyl-5-nitrobenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

482311-23-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 482311-23-9 Structure
  • Basic information

    1. Product Name: Methyl 3-Methyl-5-nitrobenzoate
    2. Synonyms: Methyl 3-Methyl-5-nitrobenzoate
    3. CAS NO:482311-23-9
    4. Molecular Formula: C9H9NO4
    5. Molecular Weight: 195.17206
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 482311-23-9.mol
  • Chemical Properties

    1. Melting Point: 84-85 °C
    2. Boiling Point: 315.0±22.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1 +-.0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl 3-Methyl-5-nitrobenzoate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl 3-Methyl-5-nitrobenzoate(482311-23-9)
    11. EPA Substance Registry System: Methyl 3-Methyl-5-nitrobenzoate(482311-23-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 482311-23-9(Hazardous Substances Data)

482311-23-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 482311-23-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,2,3,1 and 1 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 482311-23:
(8*4)+(7*8)+(6*2)+(5*3)+(4*1)+(3*1)+(2*2)+(1*3)=129
129 % 10 = 9
So 482311-23-9 is a valid CAS Registry Number.

482311-23-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 3-methyl-5-nitrobenzoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:482311-23-9 SDS

482311-23-9Downstream Products

482311-23-9Relevant articles and documents

BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS

-

Paragraph 0501-0502, (2021/11/13)

The disclosure is directed to, in part, to BCL-2 inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

FUSED BICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE

-

Paragraph 00176; 00260, (2019/03/05)

Fused bicyclic compounds and uses thereof in medicine. In particular, provided are fused bicyclic compounds used as ASK1 active regulator and and use of the compounds in the manufacture of a drug for treating a disease regulated by ASK1. Further provided are a pharmaceutical composition and a method of treating a disease regulated by ASK1 comprising administering the compounds or pharmaceutical composition thereof.

PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

-

Page/Page column 32; 48, (2018/08/12)

The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.

BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

-

Page/Page column 70, (2010/09/17)

The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 482311-23-9